Moniek Maarse, MD

Original Contribution

Prehospital Prasugrel Versus Ticagrelor in Real-World Patients With ST-Elevation Myocardial Infarction Referred for Primary PCI: Procedural and 30-Day Outcomes

10/15/2018

Mark S. Patterson , MBBS, PhD, MD, MRCP;

René J. Van Der Schaaf , MD, PhD;

Jean-Paul R. Herrman , MD, PhD;

Ton Slagboom , MD;

Maarten A. Vink , MD, PhD;

Moniek Maarse , MD;

Rob Adams , MSc;

Robbert J. de Winter , MD, PhD;

Nicola S. Vos , MD;

Giovanni Amoroso , MD, PhD;

Pretreatment with P2Y12 inhibitors before primary percutaneous coronary intervention can reduce the incidence of major adverse cardiovascular event rate in ST-segment elevation myocardial infarction patients. We investigated differences in...

Pretreatment with P2Y12...

10/15/2018

Journal of Invasive Cardiology

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

March 27 ⁠–⁠ March 30

See Full Calendar

Moniek Maarse, MD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products